|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Cash flows provided by operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for doubtful accounts | |||||
| (Benefit) provision for doubtful accounts | |||||
| Share-based compensation expense | |||||
| Deferred income taxes | |||||
| Amortization of right-of-use assets | |||||
| Amortization of debt discounts and issuance costs | |||||
| Gain on sale and disposal of fixed assets | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other current assets and other assets | |||||
| Income taxes receivable | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Accrued compensation related costs | |||||
| Other liabilities | |||||
| Operating lease liabilities, net of amortization of right-of-use assets | |||||
| Cash paid during the period for: | |||||
| Interest paid | |||||
| Income tax (refunds received) paid | |||||
| Non-cash financing and investing activities: | |||||
| Seller Notes, deferred payment obligations and additional consideration related to acquisitions | |||||
| Purchase of property, plant and equipment in accounts payable at period end | |||||
| Purchase of property, plant, and equipment through vendor financing | |||||
| Purchase of property, plant and equipment through vendor financing | |||||
| Changes in operating assets and liabilities: | |||||
| Net cash provided by operating activities | |||||
| Cash flows used in investing activities: | |||||
| Acquisitions, net of cash acquired | |||||
| Purchase of property, plant, and equipment | |||||
| Purchase of therapeutic program equipment leased to third parties under operating leases | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows used in financing activities: | |||||
| Borrowings under revolving credit agreement | |||||
| Repayments under revolving credit agreement | |||||
| Repayment of term loan | |||||
| Payment of employee taxes on stock-based compensation | |||||
| Payment of Seller Notes and additional consideration | |||||
| Payments under vendor financing arrangements | |||||
| Payment of financing lease obligations | |||||
| Payment of debt issuance costs | |||||
| Proceeds from exercise of options | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Operating lease liabilities | |||||
| Amortization of right-of-use assets | |||||
| Cash and cash equivalents, at beginning of period | |||||
| Cash, cash equivalents, and restricted cash, at beginning of period | |||||
| Cash and cash equivalents, at end of period | |||||
| Reconciliation of the Change in Operating Lease Liabilities, Net of Amortization of Right-of-Use Assets | |||||
| Operating lease liabilities | |||||
| Amortization of right-of-use assets | |||||
Loading...